Tri Locum Partners as of Sept. 30, 2021
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 25 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Walgreen Boots Alliance (WBA) | 12.4 | $31M | 663k | 47.05 | |
| Horizon Therapeutics Pub L SHS | 11.4 | $29M | 262k | 109.54 | |
| Baxter International (BAX) | 10.0 | $25M | 312k | 80.43 | |
| Merck & Co (MRK) | 9.9 | $25M | 332k | 75.11 | |
| Seagen | 6.5 | $16M | 96k | 169.80 | |
| Edwards Lifesciences (EW) | 5.5 | $14M | 123k | 113.21 | |
| The Beauty Health Company Com Cl A (SKIN) | 5.2 | $13M | 505k | 25.97 | |
| Medtronic SHS (MDT) | 5.2 | $13M | 104k | 125.35 | |
| Sarepta Therapeutics (SRPT) | 5.0 | $13M | 135k | 92.48 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.4 | $8.5M | 169k | 50.56 | |
| Regeneron Pharmaceuticals (REGN) | 3.4 | $8.4M | 14k | 605.16 | |
| Leap Therapeutics | 2.9 | $7.3M | 1.8M | 4.01 | |
| Eagle Pharmaceuticals (EGRX) | 2.7 | $6.8M | 123k | 55.78 | |
| Iveric Bio | 2.4 | $6.1M | 378k | 16.24 | |
| United Therapeutics Corporation (UTHR) | 2.4 | $6.1M | 33k | 184.59 | |
| Bellus Health Com New | 2.4 | $6.0M | 973k | 6.14 | |
| Chemocentryx | 2.0 | $5.0M | 292k | 17.08 | |
| Xenon Pharmaceuticals (XENE) | 1.6 | $4.0M | 264k | 15.28 | |
| Novavax Com New Call Option (NVAX) | 1.6 | $4.0M | 19k | 207.31 | |
| Cyclacel Pharmaceuticals | 1.1 | $2.8M | 523k | 5.27 | |
| Lifesci Acquisition Ii Corp | 1.0 | $2.6M | 263k | 9.80 | |
| Biontech Se Sponsored Ads (BNTX) | 0.6 | $1.5M | 5.5k | 272.97 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.6 | $1.5M | 148k | 9.80 | |
| Femasys (FEMY) | 0.5 | $1.3M | 191k | 6.89 | |
| Theravance Biopharma (TBPH) | 0.4 | $956k | 129k | 7.40 |
